Metoprolol Succinate (Beta-blocker)
Treatment for Hypertensive Heart Disease
Typical Dosage: 25mg - 200mg daily
Effectiveness
85%
Safety Score
70%
Clinical Trials
1,000
Participants
400K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
25mg - 200mg daily
Time to Effect
1-2 weeks for full BP effect, months for cardiac remodeling
Treatment Duration
lifetime
Evidence Quality
HIGHNumber Needed to Treat (NNT)
12(Treat 12 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
15(Treat 15 patients to see 1 additional serious adverse event)
Confidence Score
92%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$50
Monitoring:$300
Side Effect Mgmt:$75
Total Annual:$425
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$18,000/QALY
QALYs Gained
2.2
Outcome-Based Costs
Cost per Responder
$607.14
Comparison vs Lisinopril (ACE Inhibitor)
Cost Difference
+$20/year
More expensive
QALY Difference
-0.05 QALYs
Worse outcomes
Dominance
No dominance
Metoprolol Succinate (Beta-blocker) Outcomes
for Hypertensive Heart Disease
Efficacy Outcomes
Overall Effectiveness
+85%
Response Rate
+70%
Common Side Effects
Fatigue/weakness
+10%
Bradycardia
+5%
Dizziness
+5%
Erectile dysfunction
+10%
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov